By Japan Forward –
The day when regenerative medicine using induced pluripotent stem cells (iPS cells) will be used in real-world treatments is fast approaching.
For Japan to become a world leader in the field of iPS cell technologies, the government should strengthen support for practical applications and industrial development in this promising field.
A research team from Kyoto University recently conducted clinical trials in which neurons made from iPS cells were transplanted into the brains of patients with Parkinson’s disease. Results showed that there were no major safety issues and the procedure was effective in improving symptoms in some patients.
